BIOA
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against BioAge Labs, Inc. (NASDAQ: BIOA); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons...
Read moreDetails
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK , Jan. 10, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm,...
Read moreDetails
BioAge Labs (BIOA) Faces Securities Class Action On Behalf Of IPO Investors After Discontinuing Weight-Loss Drug Trial– Hagens Berman
SAN FRANCISCO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is...
Read moreDetails
BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights – BIOA
NEW YORK , Jan. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. ("BioAge" or the...
Read moreDetails
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES , Jan. 10, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces...
Read moreDetails
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit
NEW YORK , Jan. 9, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing...
Read moreDetails
BioAge Labs (BIOA) Faces Securities Class Action On Behalf Of IPO Investors After Discontinuing Weight-Loss Drug Trial- Hagens Berman
SAN FRANCISCO , Jan. 9, 2025 /PRNewswire/ -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is...
Read moreDetails
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of BioAge Labs, Inc. (BIOA) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
ATLANTA, Jan. 09, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”...
Read moreDetails
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against BioAge Labs, Inc. – BIOA
NEW YORK , Jan. 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against...
Read moreDetails
Stockholder Notice: Robbins LLP Informs Stockholders of the BioAge Labs, Inc. Class Action
SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a class action was filed on behalf of...
Read moreDetails